Department of Clinical Analysis, Toxicological and Bromatological, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Department of Pediatrics, Cystic Fibrosis Referral Service, Clinic Hospital of the Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2263-2271. doi: 10.1007/s10096-017-3058-9. Epub 2017 Aug 24.
Burkholderia sp. infections are extremely complex in cystic fibrosis (CF) patients, especially considering the lack of knowledge regarding its behavior, its relationship with prognosis, as well as its transmissibility and multidrug resistance features. This study evaluated the frequency of chronic infection by Burkholderia, using microbiological and clinical data. Ninety-eight patients with CF attended from July 2011 to April 2014 in a Brazilian reference hospital were included. Antimicrobial activity, molecular epidemiology, Shwachman score, body mass index, exacerbations, and lung function were analyzed. Nine patients had chronic colonization, and all of them showed preserved pulmonary function levels, body mass index, and Shwachman score. Meropenem was the most effective antibiotic; however, divergent results were shown by other studies. Cross-contamination may have occurred in only two unrelated patients of different ages, who were colonized by B. vietnamiensis, which does not occur frequently. Twelve new sequence types (STs) were identified and three STs have presented intercontinental distribution. None of the patients presented known epidemic strains. In conclusion, a relatively low number of patients with chronic colonization and suspected cross-infection were identified. Different from other studies that have found CF patients chronically colonized with Burkholderia sp. having a greater deterioration of lung function, more frequent antibiotic therapy, and increased mortality, in the current study, the patients showed good clinical outcomes and favorable options for antibiotics therapy. This study also updated the epidemiological database, which facilitates the multicentric collaborative analysis and assists in the control of global infection by these pathogens.
伯克霍尔德菌属感染在囊性纤维化(CF)患者中极为复杂,尤其是考虑到其行为、与预后的关系、传染性和多药耐药性特征等方面的知识匮乏。本研究通过微生物学和临床数据评估了慢性伯克霍尔德菌感染的频率。纳入了 2011 年 7 月至 2014 年 4 月在巴西一家参考医院就诊的 98 名 CF 患者。分析了抗菌活性、分子流行病学、Shwachman 评分、体重指数、恶化和肺功能。9 名患者存在慢性定植,他们的肺功能水平、体重指数和 Shwachman 评分均保持正常。美罗培南是最有效的抗生素;然而,其他研究显示了不同的结果。仅在两个不同年龄的无关联患者中发生了交叉污染,他们被不常发生的越南伯克霍尔德菌定植。鉴定出 12 种新的序列型(ST),其中 3 种 ST 具有洲际分布。患者中均未发现已知的流行株。结论是,本研究仅识别出相对较少的慢性定植和疑似交叉感染患者。与其他发现 CF 患者慢性定植伯克霍尔德菌属的研究不同,本研究中患者的肺功能恶化、抗生素治疗更频繁、死亡率更高,而在本研究中,患者的临床结局良好,抗生素治疗选择也较为有利。本研究还更新了流行病学数据库,这有助于多中心合作分析,并有助于控制这些病原体的全球感染。